Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Avacopan in a compassionate use programme for severe anti-neutrophil cytoplasmic antibody-associated vasculitis in Sweden.

Scandinavian journal of rheumatology·2026
Same author

Utilization of Oral Contraceptives and Hormone Therapy for Menopause Among Female Individuals With Migraine With Aura: A Descriptive Study.

Pharmacoepidemiology and drug safety·2025
Same author

Validation of Clinical Practice Research Datalink (CPRD) Aurum Mother-Baby Link.

Pharmacoepidemiology and drug safety·2025
Same author

Treatment for osteoporosis and risk of osteonecrosis of the jaw among female patients in the United Kingdom Clinical Practice Research Datalink.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2024
Same author

Risk of Venous Thromboembolism in Statin Users Compared to Fibrate Users in the United Kingdom Clinical Practice Research Datalink (UK CPRD) GOLD.

Clinical epidemiology·2024
Same author

Staging and clean room: Constructs designed to facilitate transparency and reduce bias in comparative analyses of real-world data.

Pharmacoepidemiology and drug safety·2024

Related Experiment Video

Updated: Jul 11, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.6K

Incident depression in patients diagnosed with multiple sclerosis: a multi-database study.

R Persson1, S Lee2, M U Yood3,4

  • 1Epidemiology, Boston Collaborative Drug Surveillance Program, Lexington, MA, USA.

European Journal of Neurology
|May 13, 2020
PubMed
Summary

Newly diagnosed depression is significantly more common in multiple sclerosis (MS) patients. This study found a two- to three-fold increased risk of new depression in MS patients compared to those without MS.

Keywords:
depressionepidemiologyincidencemultiple sclerosis

More Related Videos

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.9K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.8K

Related Experiment Videos

Last Updated: Jul 11, 2026

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.6K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.9K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

11.8K

Area of Science:

  • Neurology
  • Psychiatry
  • Epidemiology

Background:

  • Limited data exists on the incidence of newly diagnosed depression following a multiple sclerosis (MS) diagnosis.
  • Understanding depression rates in MS is crucial for patient care and management.

Purpose of the Study:

  • To quantify the incidence of treated depression in patients newly diagnosed with multiple sclerosis (MS).
  • To compare depression rates in MS patients against matched individuals without MS.

Main Methods:

  • A matched cohort study utilized two large electronic medical databases: US Department of Defense (US-DOD) and UK Clinical Practice Research Datalink GOLD (UK-CPRD).
  • Patients with a new MS diagnosis were compared with matched non-MS patients, excluding those with prior depression history.
  • Incidence rates and rate ratios for treated depression were calculated post-diagnosis/matched date.

Main Results:

  • Multiple sclerosis patients exhibited significantly higher rates of treated depression compared to non-MS controls.
  • Incidence rate ratios for treated depression were 3.20 in the US-DOD cohort and 1.90 in the UK-CPRD cohort.
  • While females with MS had higher absolute rates, males with MS showed a greater relative risk increase compared to non-MS males.

Conclusions:

  • Patients diagnosed with multiple sclerosis (MS) face a two- to three-fold increased risk of developing new, treated depression.
  • These findings highlight the importance of monitoring and addressing depression in individuals with MS.